LYON, France--(BUSINESS WIRE)--BioNet Europe, the French subsidiary of BioNet, a vaccine manufacturer specializing in the development of genetically engineered vaccines, has announced the submission ...
Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...
Revelyx Bio, Inc., a clinical-stage biopharmaceutical company, today announced its launch following an exclusive licensing ...
Chinese hamster ovary (CHO) cells have become one of the most popular cell type for recombinant antibody production – for good reason. CHO cells meet several key requirements for industrial scale ...
Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
Feature Explores the Real Biology Behind Recombinant Spider Silk and the Scientific Case for Kraig Labs' Production PlatformANN ARBOR, Mich., Sept. 03, 2026 (GLOBE NEWSWIRE) -- , Inc. (OTCQB: KBLB) ...
insights from industryDr. Tillman ZiegertManaging DirectorBiorbyt Ltd. In this interview, News-Medical speaks to Dr. Tillmann Ziegert, Managing Director at Biorbyt Ltd., about the balance between ...
insights from industryAmy ShengHead of CROSino Biological In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO program at Sino Biological US Inc., about current developments in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results